Lei Mao

Lei is a Director of Inhalation Science and Product Development at Recipharm Laboratories based in the Research Triangle Park, North Carolina, US where he heads the inhalation and product development function. Prior to joining Recipharm, Lei worked as a manager in the Pulmonary and Nasal Department at Catalent Pharm Solutions, US (2008-2018), a principal scientist and team leader at Vectura plc, UK (1998-2007) and a section head at TEVA (IVAX), UK (1996-1998). Over last twenty years, Lei has headed the development function for inhaled dosage forms including complex metered dose inhalers, dry powder inhalers, nebulizers and soft mist inhalers and supported launching of inhalation products in the US market. Lei led R&D function in a TEVA’s (IVAX’s) joint-venture in China until started to work in UK in 1996.
With Pharmacy degree and PhD in pharmaceutical sciences, Lei’s has over twenty year experience in formulation and inhalation product development in pharmaceutical industry, presents and publishes extensively in conferences, webinars, book chapters, peer reviewed journals and conference proceedings. He is a named inventor for several techniques published in fourteen patents granted worldwide.
Lei is a current IPAC-RS board member.